Compare $HYPR vs $LUCD | Chartloom

Compare

$HYPR vs $LUCD

Hyperfine Inc · Lucid Diagnostics Inc

HYPR

Hyperfine Inc

LUCD

Lucid Diagnostics Inc

Compare $HYPR vs $LUCD

Comparing Hyperfine Inc and Lucid Diagnostics Inc

HYPRHyperfine Inc

LUCDLucid Diagnostics Inc

HYPRHyperfine Inc

Market cap

$92M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.92x

Rev growth (TTM)

53.2%

YTD performance

-3.9%

52W performance

-55.5%

FCF yield

-29.8%

LUCDLucid Diagnostics Inc

Market cap

$122M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

13.06x

Rev growth (TTM)

24.9%

YTD performance

-43.0%

52W performance

-47.7%

FCF yield

-38.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HYPR

LUCD

Detailed metrics comparison

HYPR

Hyperfine Inc

LUCD

Lucid Diagnostics Inc

Market Cap

HYPR$92M

LUCD$122M

Enterprise Value

HYPR$62M

LUCD$112M

Price

HYPR$0.93

LUCD$0.64

P/E Ratio

HYPRN/A

LUCDN/A

P/S Ratio

HYPR5.59x

LUCD22.35x

EV/Sales

HYPR3.76x

LUCD20.53x

EV/EBITDA

HYPR0.00x

LUCD0.00x

P/B Ratio

HYPR2.58x

LUCD11.67x

P/FCF Ratio

HYPRN/A

LUCDN/A

EV/FCF

HYPR-2.26x

LUCD-2.37x

PEG Ratio

HYPRN/A

LUCDN/A

Forward P/E (NTM)

HYPRN/A

LUCDN/A

Forward P/S (NTM)

HYPR3.92x

LUCD13.06x

Revenue (TTM)

HYPR$17M

LUCD$5M

Revenue Growth (YoY)

HYPR53.2%

LUCD24.9%

Forward Rev Growth

HYPR30.2%

LUCD163.5%

Gross Margin (TTM)

HYPR51.4%

LUCD-21.7%

Operating Margin (TTM)

HYPR0.0%

LUCD0.0%

EBITDA Margin (TTM)

HYPR-196.5%

LUCD-914.8%

Net Margin (TTM)

HYPR-210.8%

LUCD-1193.9%

FCF Margin (TTM)

HYPR-166.5%

LUCD-866.6%

Net Income (TTM)

HYPR$-35M

LUCD$-65M

FCF (TTM)

HYPR$-28M

LUCD$-47M

EPS (TTM)

HYPR-$0.35

LUCD-$0.35

ROE (TTM)

HYPR-10030.0%

LUCD-40434.0%

ROA (TTM)

HYPR-6334.0%

LUCD-12542.0%

ROIC (TTM)

HYPR-8431.0%

LUCD-14249.0%

Cash

HYPR$43M

LUCD$33M

Debt

HYPR$13M

LUCD$24M

Net Cash/Debt

HYPR$30M

LUCD$10M

Current Ratio (TTM)

HYPR6.15x

LUCD1.33x

Quick Ratio (TTM)

HYPR5.25x

LUCD1.29x

Debt/Equity (TTM)

HYPR0.36x

LUCD2.15x

Debt/Assets (TTM)

HYPR0.0%

LUCD0.0%

Interest Coverage (TTM)

HYPRN/A

LUCDN/A

Net Debt/EBITDA (TTM)

HYPR0.00x

LUCD0.00x

Beta

HYPR1.51

LUCD1.16

52W Performance

HYPR-55.5%

LUCD-47.7%

YTD Performance

HYPR-3.9%

LUCD-43.0%

% from 52W High

HYPR-58.1%

LUCD-60.8%

% from 52W Low

HYPR23.5%

LUCD27.6%

Asset Turnover (TTM)

HYPR0.30x

LUCD0.13x

FCF Yield (TTM)

HYPR-29.8%

LUCD-38.8%

Earnings Yield (TTM)

HYPR-37.7%

LUCD-53.4%

Dividend Yield (TTM)

HYPRN/A

LUCDN/A

Rule of 40

HYPR-113.3

LUCD-841.7

EV/GP/RG

HYPR0.17

LUCDN/A

Ticker research

View HYPR research View LUCD research

Metric	HYPR Hyperfine Inc	LUCD Lucid Diagnostics Inc
Market & Valuation
Market Cap	$92M	$122M
Enterprise Value	$62M	$112M
Price	$0.93	$0.64
P/E Ratio	N/A	N/A
P/S Ratio	5.59x	22.35x
EV/Sales	3.76x	20.53x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	11.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.26x	-2.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.92x	13.06x
Revenue & Growth
Revenue (TTM)	$17M	$5M
Revenue Growth (YoY)	53.2%	24.9%
Forward Rev Growth	30.2%	163.5%
Profitability
Gross Margin (TTM)	51.4%	-21.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-196.5%	-914.8%
Net Margin (TTM)	-210.8%	-1193.9%
FCF Margin (TTM)	-166.5%	-866.6%
Net Income (TTM)	$-35M	$-65M
FCF (TTM)	$-28M	$-47M
EPS (TTM)	-$0.35	-$0.35
ROE (TTM)	-10030.0%	-40434.0%
ROA (TTM)	-6334.0%	-12542.0%
ROIC (TTM)	-8431.0%	-14249.0%
Financial Health
Cash	$43M	$33M
Debt	$13M	$24M
Net Cash/Debt	$30M	$10M
Current Ratio (TTM)	6.15x	1.33x
Quick Ratio (TTM)	5.25x	1.29x
Debt/Equity (TTM)	0.36x	2.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.16
52W Performance	-55.5%	-47.7%
YTD Performance	-3.9%	-43.0%
% from 52W High	-58.1%	-60.8%
% from 52W Low	23.5%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.30x	0.13x
FCF Yield (TTM)	-29.8%	-38.8%
Earnings Yield (TTM)	-37.7%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-113.3	-841.7
EV/GP/RG	0.17	N/A
Ticker research	View HYPR research	View LUCD research

Valuation

P/S Ratio

HYPR

5.59x

LUCD

22.35x

EV/FCF

LUCD

-2.37x

HYPR

-2.26x

Growth & revenue

Revenue Growth TTM

HYPR

53.2%

LUCD

24.9%

Forward Revenue Growth

LUCD

163.5%

HYPR

30.2%

Profitability & performance

Gross Margin

HYPR

51.4%

LUCD

-21.7%

ROE

HYPR

-10030.0%

LUCD

-40434.0%

FCF Yield %

HYPR

-29.8%

LUCD

-38.8%

52-Week Performance

LUCD

-47.7%

HYPR

-55.5%

Detailed metrics comparison

HYPR

Hyperfine Inc

LUCD

Lucid Diagnostics Inc

Market Cap

HYPR$92M

LUCD$122M

Enterprise Value

HYPR$62M

LUCD$112M

Price

HYPR$0.93

LUCD$0.64

P/E Ratio

HYPRN/A

LUCDN/A

P/S Ratio

HYPR5.59x

LUCD22.35x

EV/Sales

HYPR3.76x

LUCD20.53x

EV/EBITDA

HYPR0.00x

LUCD0.00x

P/B Ratio

HYPR2.58x

LUCD11.67x

P/FCF Ratio

HYPRN/A

LUCDN/A

EV/FCF

HYPR-2.26x

LUCD-2.37x

PEG Ratio

HYPRN/A

LUCDN/A

Forward P/E (NTM)

HYPRN/A

LUCDN/A

Forward P/S (NTM)

HYPR3.92x

LUCD13.06x

Revenue (TTM)

HYPR$17M

LUCD$5M

Revenue Growth (YoY)

HYPR53.2%

LUCD24.9%

Forward Rev Growth

HYPR30.2%

LUCD163.5%

Gross Margin (TTM)

HYPR51.4%

LUCD-21.7%

Operating Margin (TTM)

HYPR0.0%

LUCD0.0%

EBITDA Margin (TTM)

HYPR-196.5%

LUCD-914.8%

Net Margin (TTM)

HYPR-210.8%

LUCD-1193.9%

FCF Margin (TTM)

HYPR-166.5%

LUCD-866.6%

Net Income (TTM)

HYPR$-35M

LUCD$-65M

FCF (TTM)

HYPR$-28M

LUCD$-47M

EPS (TTM)

HYPR-$0.35

LUCD-$0.35

ROE (TTM)

HYPR-10030.0%

LUCD-40434.0%

ROA (TTM)

HYPR-6334.0%

LUCD-12542.0%

ROIC (TTM)

HYPR-8431.0%

LUCD-14249.0%

Cash

HYPR$43M

LUCD$33M

Debt

HYPR$13M

LUCD$24M

Net Cash/Debt

HYPR$30M

LUCD$10M

Current Ratio (TTM)

HYPR6.15x

LUCD1.33x

Quick Ratio (TTM)

HYPR5.25x

LUCD1.29x

Debt/Equity (TTM)

HYPR0.36x

LUCD2.15x

Debt/Assets (TTM)

HYPR0.0%

LUCD0.0%

Interest Coverage (TTM)

HYPRN/A

LUCDN/A

Net Debt/EBITDA (TTM)

HYPR0.00x

LUCD0.00x

Beta

HYPR1.51

LUCD1.16

52W Performance

HYPR-55.5%

LUCD-47.7%

YTD Performance

HYPR-3.9%

LUCD-43.0%

% from 52W High

HYPR-58.1%

LUCD-60.8%

% from 52W Low

HYPR23.5%

LUCD27.6%

Asset Turnover (TTM)

HYPR0.30x

LUCD0.13x

FCF Yield (TTM)

HYPR-29.8%

LUCD-38.8%

Earnings Yield (TTM)

HYPR-37.7%

LUCD-53.4%

Dividend Yield (TTM)

HYPRN/A

LUCDN/A

Rule of 40

HYPR-113.3

LUCD-841.7

EV/GP/RG

HYPR0.17

LUCDN/A

Ticker research

View HYPR research View LUCD research

Metric	HYPR Hyperfine Inc	LUCD Lucid Diagnostics Inc
Market & Valuation
Market Cap	$92M	$122M
Enterprise Value	$62M	$112M
Price	$0.93	$0.64
P/E Ratio	N/A	N/A
P/S Ratio	5.59x	22.35x
EV/Sales	3.76x	20.53x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	11.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.26x	-2.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.92x	13.06x
Revenue & Growth
Revenue (TTM)	$17M	$5M
Revenue Growth (YoY)	53.2%	24.9%
Forward Rev Growth	30.2%	163.5%
Profitability
Gross Margin (TTM)	51.4%	-21.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-196.5%	-914.8%
Net Margin (TTM)	-210.8%	-1193.9%
FCF Margin (TTM)	-166.5%	-866.6%
Net Income (TTM)	$-35M	$-65M
FCF (TTM)	$-28M	$-47M
EPS (TTM)	-$0.35	-$0.35
ROE (TTM)	-10030.0%	-40434.0%
ROA (TTM)	-6334.0%	-12542.0%
ROIC (TTM)	-8431.0%	-14249.0%
Financial Health
Cash	$43M	$33M
Debt	$13M	$24M
Net Cash/Debt	$30M	$10M
Current Ratio (TTM)	6.15x	1.33x
Quick Ratio (TTM)	5.25x	1.29x
Debt/Equity (TTM)	0.36x	2.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.16
52W Performance	-55.5%	-47.7%
YTD Performance	-3.9%	-43.0%
% from 52W High	-58.1%	-60.8%
% from 52W Low	23.5%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.30x	0.13x
FCF Yield (TTM)	-29.8%	-38.8%
Earnings Yield (TTM)	-37.7%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-113.3	-841.7
EV/GP/RG	0.17	N/A
Ticker research	View HYPR research	View LUCD research